PubMed

Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus.

Shiratori Y, Shiina S, Teratani T, Imamura M, Obi S, Sato S, Koike Y, Yoshida H, Omata M.

Ann Intern Med. 2003 Feb 18;138(4):299-306.PMID: 12585827 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Interferon therapy improves survival in patients with liver cancer and hepatitis C virus infection.

[No authors listed]

Ann Intern Med. 2003 Feb 18;138(4):I52. No abstract available. PMID: 12585851 [PubMed - indexed for MEDLINE]Related articlesFree article

Interferon therapy for hepatocellular carcinoma patients with low HCV-RNA levels.

Miyaguchi S, Watanabe T, Takahashi H, Nakamura M, Saito H, Ishii H.

Hepatogastroenterology. 2002 May-Jun;49(45):724-9.PMID: 12063979 [PubMed - indexed for MEDLINE]Related articles

Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival.

Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, Arakawa Y, Hashimoto E, Hirota K, Yoshida H, Ohashi Y, Omata M; Tokyo-Chiba Hepatitis Research Group.

Ann Intern Med. 2005 Jan 18;142(2):105-14.PMID: 15657158 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiviral therapy after non-surgical tumor ablation in patients with hepatocellular carcinoma associated with hepatitis C virus.

Hung CH, Lee CM, Wang JH, Tung HD, Chen CH, Lu SN.

J Gastroenterol Hepatol. 2005 Oct;20(10):1553-9.PMID: 16174073 [PubMed - indexed for MEDLINE]Related articles

Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.

Jeong SC, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K.

World J Gastroenterol. 2007 Oct 28;13(40):5343-50.PMID: 17879404 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma.

Sakaguchi Y, Kudo M, Fukunaga T, Minami Y, Chung H, Kawasaki T.

Intervirology. 2005 Jan-Feb;48(1):64-70.PMID: 15785092 [PubMed - indexed for MEDLINE]Related articles

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer.

Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H.

Hepatology. 2000 Aug;32(2):228-32.PMID: 10915728 [PubMed - indexed for MEDLINE]Related articles

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M.

Ann Intern Med. 1999 Aug 3;131(3):174-81.PMID: 10428733 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.

Omata M, Yoshida H, Shiratori Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3. Review.PMID: 16234063 [PubMed - indexed for MEDLINE]Related articles

Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis.

Gramenzi A, Andreone P, Fiorino S, Cammà C, Giunta M, Magalotti D, Cursaro C, Calabrese C, Arienti V, Rossi C, Di Febo G, Zoli M, Craxì A, Gasbarrini G, Bernardi M.

Gut. 2001 Jun;48(6):843-8.PMID: 11358906 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of interferon alpha treatment on recurrence and survival after complete resection or ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

Zhang CH, Xu GL, Jia WD, Ge YS.

Int J Cancer. 2009 Jun 15;124(12):2982-8.PMID: 19296539 [PubMed - indexed for MEDLINE]Related articles

Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.

Castellano L, Calandra M, Del Vecchio Blanco C, de Sio I.

J Hepatol. 1997 Nov;27(5):862-70.PMID: 9382974 [PubMed - indexed for MEDLINE]Related articles

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, Shiomi S, Tamori A, Oka H, Igawa S, Kuroki T, Kinoshita H.

Ann Intern Med. 2001 May 15;134(10):963-7.PMID: 11352697 [PubMed - indexed for MEDLINE]Related articlesFree article

Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients.

Ikeda K, Kobayashi M, Saitoh S, Someya T, Hosaka T, Akuta N, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Kumada H.

Oncology. 2003;65(3):204-10.PMID: 14657593 [PubMed - indexed for MEDLINE]Related articles

Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma.

Nishiguchi S, Tamori A, Kubo S.

Intervirology. 2005 Jan-Feb;48(1):71-5.PMID: 15785093 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.

Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G.

Cancer. 2001 Jul 1;92(1):126-35.PMID: 11443618 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.

Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, Takahashi S, Kitai S, Inoue T, Minami Y, Ueshima K.

Oncology. 2007;72 Suppl 1:132-8. Epub 2007 Dec 13.PMID: 18087194 [PubMed - indexed for MEDLINE]Related articles

Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.

Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U.

Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8.PMID: 12397752 [PubMed - indexed for MEDLINE]Related articles

Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.

[No authors listed]

Lancet. 1998 May 23;351(9115):1535-9. Erratum in: Lancet 1998 Oct 10;352(9135):1230. PMID: 10326535 [PubMed - indexed for MEDLINE]Related articles